# An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With Asthma

> **NCT03478657** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 222 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Placebo DPI
- **DEVICE:** ELLIPTA DPI
- **OTHER:** Ease of use questionnaires

## Key facts

- **NCT ID:** NCT03478657
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-18
- **Primary completion:** 2018-12-07
- **Final completion:** 2018-12-07
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2021-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03478657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03478657, "An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With Asthma". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03478657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*